Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Change in management at Genmab

This article was originally published in Scrip

Executive Summary

Genmab (Denmark) has announced that Dr Claus Møller is to step down from his position as executive vice-president and chief operating officer. He will remain available to the company as Development Advisor for the remainder of 2008. The COO position at Genmab will be discontinued and Dr Møller's responsibilities will be folded into the R&D department which has already been consolidated under the direction of Professor Jan van de Winkel, president of R&D and chief scientific officer.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC032161

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel